back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2023-02-24 09:36 Tx date 2023-02-19 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Burke, Robert
4 - Director of Issuer
Direct Ownership
|
Options Stock Options
50 - Grant of options
|
$29,786
+7,265 vol $4.10 each |
52,265 | |
| Filed 2022-08-18 08:56 Tx date 2022-08-17 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Burke, Robert
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$7,310
+1,000 vol $7.31 each |
31,000 | |
| Filed 2021-10-22 11:28 Tx date 2021-10-19 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Burke, Robert
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
+20,000 vol |
30,000 | |
| Filed 2021-10-22 11:27 Tx date 2021-10-19 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Burke, Robert
4 - Director of Issuer
Direct Ownership
|
Options Stock Options
51 - Exercise of options
|
-20,000 vol |
45,000 | |
| Filed 2021-05-13 15:30 Tx date 2021-05-13 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Burke, Robert
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$19,000
+2,000 vol $9.50 each |
10,000 | |
| Filed 2021-01-08 11:00 Tx date 2021-01-06 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Burke, Robert
4 - Director of Issuer
Direct Ownership
|
Options Stock Options
50 - Grant of options
|
+5,000 vol |
65,000 | |
| Filed 2021-01-08 10:27 Tx date 2020-11-23 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Burke, Robert
4 - Director of Issuer
Direct Ownership
|
Options Stock Options
37 - Stock split or consolidation
|
-240,000 vol |
60,000 | |
| Filed 2021-01-08 10:26 Tx date 2020-11-23 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Burke, Robert
4 - Director of Issuer
Holder: Elizabeth Grant (Control or Direction)
|
Common Shares
37 - Stock split or consolidation
|
-34,400 vol |
8,600 | |
| Filed 2021-01-08 10:25 Tx date 2020-11-23 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Burke, Robert
4 - Director of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
-32,000 vol |
8,000 | |
| Filed 2020-01-10 15:06 Tx date 2020-01-09 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Burke, Robert
4 - Director of Issuer
Holder: Elizabeth Grant (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$15,400
+28,000 vol $0.55 each |
43,000 | |
| Filed 2020-01-10 15:05 Tx date 2020-01-09 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Burke, Robert
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$13,750
+25,000 vol $0.55 each |
40,000 | |
| Filed 2019-01-10 Tx date 2017-12-18 |
$IPA
ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.") |
Burke, Robert
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2019-01-10 Tx date 2019-01-09 |
$IPA
ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.") |
Burke, Robert
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$5,475
+7,500 vol $0.73 each |
15,000 | |
| Filed 2019-01-10 Tx date 2017-12-18 |
$IPA
ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.") |
Burke, Robert
4 - Director of Issuer
Holder: Elizabeth Grant (Control or Direction)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2019-01-10 Tx date 2019-01-08 |
$IPA
ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.") |
Burke, Robert
4 - Director of Issuer
Holder: Elizabeth Grant (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$10,950
+15,000 vol $0.73 each |
15,000 | |
| Filed 2019-01-10 Tx date 2019-01-08 |
$IPA
ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.") |
Burke, Robert
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$5,475
+7,500 vol $0.73 each |
7,500 | |
| Filed 2019-01-03 Tx date 2017-12-18 |
$IPA
ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.") |
Burke, Robert
4 - Director of Issuer
Direct Ownership
|
Options Stock Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2019-01-03 Tx date 2018-12-31 |
$IPA
ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.") |
Burke, Robert
4 - Director of Issuer
Direct Ownership
|
Options Stock Options
50 - Grant of options
|
$200,000
+200,000 vol $1.00 each |
300,000 | |
| Filed 2019-01-03 Tx date 2017-12-18 |
$IPA
ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.") |
Burke, Robert
4 - Director of Issuer
Direct Ownership
|
Options Stock Options
00 - Opening Balance-Initial SEDI Report
|
100,000 |